Randomized, Double-Blind, and Placebo-Controlled Study Using Eculizumab in Transfusion Dependent PNH Patients
Randomized, Double-Blind, and Placebo-Controlled Study Using Eculizumab in Transfusion Dependent PNH Patients
The primary objective is to evaluate the safety and efficacy of eculizumab in transfusion dependent patients with hemolytic PNH.
Inclusion Criteria:
Exclusion Criteria:
Duarte, California 91010-3000, United States
Stanford, California 94305-5821, United States
Indianapolis, Indiana 46202, United States
Bethesda, Maryland 20892, United States
St Louis, Missouri 63110-1093, United States
Durham, North Carolina 27710, United States
Philadelphia, Pennsylvania 19104, United States
Woolloongabba, Queensland 4102, Australia
Parkville, Victoria 3050, Australia
Cedex, Paris 04 75181, France
Cedex, Paris 10 75475, France
Hanover, D-30625, Germany
Homburg/Saar, D-66421, Germany
Ulm, D-89081, Germany
Florence, 50139, Italy
Naples, 5-80131, Italy
Lund, SE-22185, Sweden